Bio-Rad receives Frost and Sullivan's Adme/Tox informatics product differentiation innovation award for its KnowItAll software
Bio-Rad Laboratories has received Frost and Sullivan's Adme/Tox informatics product differentiation innovation award. This award is presented annually to one company that demonstrates the ability to produce the most innovative products in this category.
Frost and Sullivan selects the award recipient based on market participant interviews, end-user surveys, and extensive secondary research.
Gregory Banik, general manager of Bio-Rad's informatics division, remarked: "This award distinguishes KnowItAll's Adme/Tox environment from other systems on the market and speaks to the excellence of our Adme/Tox informatics product line as a whole.
"Specifically, it recognises the contributions made by our collaborators at ComGenex/CompuDrug International, ChemSilico, and Syracuse Research, whose outstanding development teams have produced many of the cutting-edge tools that help make KnowItAll a complete in silico Adme/Tox solution for the drug discovery community." Bio-Rad's award-winning KnowItAll informatics system offers a complete and fully integrated software environment for Adme/Tox prediction, including tools for structure drawing, database management, and customised reporting.
With KnowItAll, drug discovery professionals can generate in silico Adme/Tox profiles for potential lead compounds and accelerate lead generation with the largest collection of prediction models, multiple models for more accurate predictions, powerful validation tools to verify models, and integrated tools for improved workflow.
